Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Chronic obstructive pulmonary disease: a complex comorbidity of lung cancer.

Grose D, Milroy R.

J Comorb. 2011 Dec 27;1:45-50. eCollection 2011. Review.

2.

How Intravenous Nicotine Administration in Smokers Can Inform Tobacco Regulatory Science.

Jensen KP, DeVito EE, Sofuoglu M.

Tob Regul Sci. 2016 Oct;2(4):452-463. doi: 10.18001/TRS.2.4.14. Epub 2016 Oct 1.

3.

Chronic Obstructive Pulmonary Disease Genetics: A Review of the Past and a Look Into the Future.

Hardin M, Silverman EK.

Chronic Obstr Pulm Dis. 2014 May 6;1(1):33-46. doi: 10.15326/jcopdf.1.1.2014.0120.

4.

Quantifying the Genetic Correlation between Multiple Cancer Types.

Lindström S, Finucane H, Bulik-Sullivan B, Schumacher FR, Amos CI, Hung RJ, Rand K, Gruber SB, Conti D, Permuth JB, Lin HY, Goode EL, Sellers TA, Amundadottir LT, Stolzenberg-Solomon R, Klein A, Petersen G, Risch H, Wolpin B, Hsu L, Huyghe JR, Chang-Claude J, Chan A, Berndt S, Eeles R, Easton D, Haiman CA, Hunter DJ, Neale B, Price AL, Kraft P; PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO.

Cancer Epidemiol Biomarkers Prev. 2017 Sep;26(9):1427-1435. doi: 10.1158/1055-9965.EPI-17-0211. Epub 2017 Jun 21.

PMID:
28637796
5.

Uncovering the transcriptomic and epigenomic landscape of nicotinic receptor genes in non-neuronal tissues.

Zhang B, Madden P, Gu J, Xing X, Sankar S, Flynn J, Kroll K, Wang T.

BMC Genomics. 2017 Jun 5;18(1):439. doi: 10.1186/s12864-017-3813-4.

6.

Genetic variation in the exome: Associations with alcohol and tobacco co-use.

Otto JM, Gizer IR, Ellingson JM, Wilhelmsen KC.

Psychol Addict Behav. 2017 May;31(3):354-366. doi: 10.1037/adb0000270. Epub 2017 Apr 3.

PMID:
28368157
7.

Genetic susceptibility variants for lung cancer: replication study and assessment as expression quantitative trait loci.

Pintarelli G, Cotroneo CE, Noci S, Dugo M, Galvan A, Delli Carpini S, Citterio L, Manunta P, Incarbone M, Tosi D, Santambrogio L, Dragani TA, Colombo F.

Sci Rep. 2017 Feb 9;7:42185. doi: 10.1038/srep42185.

8.

The CHRNA5-A3-B4 Gene Cluster and Smoking: From Discovery to Therapeutics.

Lassi G, Taylor AE, Timpson NJ, Kenny PJ, Mather RJ, Eisen T, Munafò MR.

Trends Neurosci. 2016 Dec;39(12):851-861. doi: 10.1016/j.tins.2016.10.005. Epub 2016 Nov 18. Review.

9.

The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.

Barrie ES, Hartmann K, Lee SH, Frater JT, Seweryn M, Wang D, Sadee W.

Hum Mutat. 2017 Jan;38(1):112-119. doi: 10.1002/humu.23135. Epub 2016 Nov 7.

PMID:
27758088
10.

A Review of Genome-Wide Association Studies of Stimulant and Opioid Use Disorders.

Jensen KP.

Mol Neuropsychiatry. 2016 May;2(1):37-45. doi: 10.1159/000444755. Epub 2016 Apr 13. Review.

11.

Meta-Analyses of Genome-Wide Association Data Hold New Promise for Addiction Genetics.

Agrawal A, Edenberg HJ, Gelernter J.

J Stud Alcohol Drugs. 2016 Sep;77(5):676-80.

12.

Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-Analysis.

Chen LS, Baker T, Hung RJ, Horton A, Culverhouse R, Hartz S, Saccone N, Cheng I, Deng B, Han Y, Hansen HM, Horsman J, Kim C, Rosenberger A, Aben KK, Andrew AS, Chang SC, Saum KU, Dienemann H, Hatsukami DK, Johnson EO, Pande M, Wrensch MR, McLaughlin J, Skaug V, van der Heijden EH, Wampfler J, Wenzlaff A, Woll P, Zienolddiny S, Bickeböller H, Brenner H, Duell EJ, Haugen A, Brüske I, Kiemeney LA, Lazarus P, Le Marchand L, Liu G, Mayordomo J, Risch A, Schwartz AG, Teare MD, Wu X, Wiencke JK, Yang P, Zhang ZF, Spitz MR, Amos CI, Bierut LJ.

EBioMedicine. 2016 Sep;11:219-226. doi: 10.1016/j.ebiom.2016.08.012. Epub 2016 Aug 10.

13.

Polygenic risk scores for cigarettes smoked per day do not generalize to a Native American population.

Otto JM, Gizer IR, Bizon C, Wilhelmsen KC, Ehlers CL.

Drug Alcohol Depend. 2016 Oct 1;167:95-102. doi: 10.1016/j.drugalcdep.2016.07.029. Epub 2016 Aug 10.

14.

Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population.

Zanetti KA, Wang Z, Aldrich M, Amos CI, Blot WJ, Bowman ED, Burdette L, Cai Q, Caporaso N, Chung CC, Gillanders EM, Haiman CA, Hansen HM, Henderson BE, Kolonel LN, Marchand LL, Li S, McNeill LH, Ryan BM, Schwartz AG, Sison JD, Spitz MR, Tucker M, Wenzlaff AS, Wiencke JK, Wilkens L, Wrensch MR, Wu X, Zheng W, Zhou W, Christiani D, Palmer JR, Penning TM, Rieber AG, Rosenberg L, Ruiz-Narvaez EA, Su L, Vachani A, Wei Y, Whitehead AS, Chanock SJ, Harris CC.

Lung Cancer. 2016 Aug;98:33-42. doi: 10.1016/j.lungcan.2016.05.008. Epub 2016 May 13.

15.

Genetic influences on nicotinic α5 receptor (CHRNA5) CpG methylation and mRNA expression in brain and adipose tissue.

Ramsay JE, Rhodes CH, Thirtamara-Rajamani K, Smith RM.

Genes Environ. 2015 Oct 1;37:14. doi: 10.1186/s41021-015-0020-x. eCollection 2015.

16.

Associations between smoking behavior-related alleles and the risk of melanoma.

Wu W, Liu H, Song F, Chen LS, Kraft P, Wei Q, Han J.

Oncotarget. 2016 Jul 26;7(30):47366-47375. doi: 10.18632/oncotarget.10144.

17.

Sharp sensitivity bounds for mediation under unmeasured mediator-outcome confounding.

Ding P, Vanderweele TJ.

Biometrika. 2016 Jun;103(2):483-490. Epub 2016 Apr 30.

18.

Converging findings from linkage and association analyses on susceptibility genes for smoking and other addictions.

Yang J, Li MD.

Mol Psychiatry. 2016 Aug;21(8):992-1008. doi: 10.1038/mp.2016.67. Epub 2016 May 10. Review.

20.

Risky Business: Pathways to Progress in Biologically Informed Studies of Psychopathology.

Agrawal A, Bogdan R.

Psychol Inq. 2015;26(3):231-238. Epub 2015 Aug 28. No abstract available.

Supplemental Content

Support Center